These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9756988)

  • 1. The Tat protein of equine infectious anemia virus (EIAV) activates cellular gene expression by read-through transcription.
    Rosin-Arbesfeld R; Willbold D; Yaniv A; Gazit A
    Gene; 1998 Sep; 219(1-2):25-35. PubMed ID: 9756988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
    Maury WJ; Carpenter S; Graves K; Chesebro B
    Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the equine infectious anemia virus Tat-responsive element.
    Carvalho M; Derse D
    J Virol; 1991 Jul; 65(7):3468-74. PubMed ID: 1645778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat).
    Derse D; Dorn P; DaSilva L; Martarano L
    Dev Biol Stand; 1990; 72():39-48. PubMed ID: 2178129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity and intracellular location of the Tat protein of equine infectious anemia virus.
    Rosin-Arbesfeld R; Mashiah P; Willbold D; Rosch P; Tronick SR; Yaniv A; Gazit A
    Gene; 1994 Dec; 150(2):307-11. PubMed ID: 7821797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Mol Cell Biol; 1999 Jul; 19(7):4592-9. PubMed ID: 10373508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1.
    Taube R; Fujinaga K; Irwin D; Wimmer J; Geyer M; Peterlin BM
    J Virol; 2000 Jan; 74(2):892-8. PubMed ID: 10623752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sequences encoding the equine infectious anemia virus tat gene.
    Noiman S; Gazit A; Tori O; Sherman L; Miki T; Tronick SR; Yaniv A
    Virology; 1990 May; 176(1):280-8. PubMed ID: 2158694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein.
    Beisel CE; Edwards JF; Dunn LL; Rice NR
    J Virol; 1993 Feb; 67(2):832-42. PubMed ID: 8419648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis of EIAV TAT reveals structural features essential for transcriptional activation and TAR element recognition.
    Derse D; Newbold SH
    Virology; 1993 Jun; 194(2):530-6. PubMed ID: 8389074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.
    Schiltz RL; Shih DS; Rasty S; Montelaro RC; Rushlow KE
    J Virol; 1992 Jun; 66(6):3455-65. PubMed ID: 1316461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CAEV tat gene trans-activates the viral LTR and is necessary for efficient viral replication.
    Saltarelli MJ; Schoborg R; Gdovin SL; Clements JE
    Virology; 1993 Nov; 197(1):35-44. PubMed ID: 8212571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats.
    Sherman L; Yaniv A; Lichtman-Pleban H; Tronick SR; Gazit A
    J Virol; 1989 Nov; 63(11):4925-31. PubMed ID: 2552171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient trans-activation by the HIV-2 Tat protein requires a duplicated TAR RNA structure.
    Berkhout B; Gatignol A; Silver J; Jeang KT
    Nucleic Acids Res; 1990 Apr; 18(7):1839-46. PubMed ID: 2186367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon.
    Carroll R; Derse D
    J Virol; 1993 Mar; 67(3):1433-40. PubMed ID: 8382305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RNA element encoded by the trans-activation-responsive region of human immunodeficiency virus type 1 is functional when displaced downstream of the start of transcription.
    Churcher MJ; Lowe AD; Gait MJ; Karn J
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2408-12. PubMed ID: 7892280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.